News summary

Four societies now stage women’s cardiovascular prevention by female life stage

Source: Longevity Docs News • Published: 20 Nov 2026, 00:00

Summarized by Masters of Longevity from Longevity Docs News.

A three-paper advisory reframes prevention around reproductive life stages and menstrual history.

Four societies now stage women’s cardiovascular prevention by female life stage
Key Takeaways
  • The framework is built on hormonal biology, not age alone.
  • Perimenopause is flagged as a key window for cardiovascular risk.
  • Pregnancy is treated as a cardiovascular stress test modifier.
Read the full article at Longevity Docs News ↗

Continue exploring

Recommended MoL Picks

MoL PickApoB: The cholesterol signal LDL can missIn longevity medicine, the useful biomarkers are not always the exotic ones. ApoB is a relatively simple blood test that can sharpen cardiovascular prevention when LDL-C looks reassuring but particle burden remains high.MoL PickBiotin for Hair Growth: The Weak Evidence—and the Blood-Test Risk Most People MissBiotin deficiency can affect hair. That does not mean more biotin makes healthy hair grow—and high doses can distort important laboratory results.MoL PickSemaglutide Extended Lifespan in Mice. What Would Make It a Human Longevity Drug?A new animal study sharpens an important question: when do benefits in a particular disease become evidence for a longer, healthier life?